CNE1000040M1
CNE1000040M1
TIGERMED
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 38.37B EUR | 29.93B EUR | 35.68B EUR |
Enterprise Value | 44.11B EUR | 30.17B EUR | 35.23B EUR |
Valuation Multiples | |||
Trailing P/E | 371.33x | -- | 119x |
Forward P/E | 33.93x | -- | -- |
Price to Sales | 5.26x | 4.16x | 5.2x |
Price to Book | 1.77x | 1.54x | 1.71x |
EV/Revenue | 6.05x | 4.19x | 5.14x |
EV/EBITDA | 50.94x | 18.64x | 24.54x |
Price to FCF (P/FCF) | 40.43x | 36.71x | 39.09x |
EV/FCF | 46.48x | 37.01x | 38.6x |
FCF Yield | 2.47% | 2.72% | 2.56% |